Daily Brief: GDPR and NHS Opt Out Day, BioMarin's new rare disease approval and more

It's not just the GDPR's big day, plus news from Medigene and Pfizer

More From BioPortfolio on "Daily Brief: GDPR and NHS Opt Out Day, BioMarin's new rare disease approval and more"